Ticker Details
Lyell Immunopharma, Inc.
IPO Date:	June 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$380.56M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 4.28%
Avg Daily Range (30 D):	$0.44 | 3.16%
Avg Daily Range (90 D):	$0.58 | 3.72%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.14M
Avg Daily Volume (90 D):	.11M

Trade Size
Avg Trade Size (Sh.):	123
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	356
Avg Institutional Trade:	$1.97M
Avg Institutional Trade (30 D):	$.95M
Avg Institutional Trade (90 D):	$2.41M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.33M
Avg Closing Trade (30 D):	$.59M
Avg Closing Trade (90 D):	$3.89M
Avg Closing Volume:	34.95K

News

Jun 12, 2026 @ 4:45 PM Lyell Immunopharma Presents Updated Safety Data an... Source: Na

Jun 8, 2026 @ 10:00 AM Lyell Immunopharma Provides Update on Safety Profi... Source: Na

Mar 9, 2026 @ 12:00 PM Lyell Immunopharma Announces Closing of Additional... Source: Na

Dec 9, 2025 @ 1:00 PM Century Therapeutics Appoints Accomplished Biotech... Source: Century Therapeutics

Dec 7, 2025 @ 9:30 PM Lyell Immunopharma Presents New Clinical Data from... Source: Lyell Immunopharma

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-12.86	$-1.92	$-1.1
Diluted EPS	$-12.86	$-1.92	$-1.1
Revenue	$.03M	$M	$M
Gross Profit
Net Income / Loss	$-248.48M	$-44.76M	$-24.15M
Operating Income / Loss	$-256.5M	$-47.34M	$-44.26M
Cost of Revenue
Net Cash Flow	$-25.82M	$-17.78M	$30.59M
PE Ratio

Splits
Jun 02, 2025	1:20